Subtle brain dysfunction in treated 6-pyruvoyl-tetrahydropterin synthase deficiency: Relationship to motor tasks and neurophysiological tests

Brain and Development

Volumn 26, Issue 2, 2004, Pages 93-98

  Kao, Chuen Der ^a,b   Niu, Dau Ming ^a,b   Chen, Jen Tse ^a,b,c   Shan, Din E ^a,b   Lin, Yung Yang ^a,b   Wu, Zin An ^a,b   Liao, Kwong Kum ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

6 Pyruvoyl tetrahydropterin synthase; Cortical excitability; Movement rhythm variation

Indexed keywords

6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; TETRAHYDROBIOPTERIN;

6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE DEFICIENCY; ADOLESCENT; ADULT; ARTICLE; AUDITORY STIMULATION; BRAIN DYSFUNCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HAND MUSCLE; HUMAN; MALE; MEDIAN NERVE; MOTOR ACTIVITY; MOTOR NERVE CONDUCTION; MUSCLE CONTRACTION; NERVE STIMULATION; NEUROPHYSIOLOGY; REACTION TIME; TASK PERFORMANCE; TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT;

EID: 1242339737     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00098-6     Document Type: Article

References (29)

1. Smith I., Lee P. The hyperphenylalaninaemias. Fernandes J., Saudubray J.M., Van Den Berghe G. Inborn metabolic diseases. 3rd ed. 2000;171-184 Springer, Berlin.
2. Liu T.T., Chiang S.H., Wu S.J., Hsiao K.J. Tetrahydrobiopterin deficient hyperphenylalaninemia in the Chinese. Clin Chim Acta. 313:2001;157-169.
3. Hsiao K.J., Chiang S.H., Liu T.T., Chiu P.C. Tetrahydrobiopterin deficient phenylketonuria detected by neonatal screening in Taiwan. Curtis H.C., Ghisla S., Blau N. Chemistry and biology of pteridines 1989. 1990;402-407 Walter De Gruyter, Berlin.
4. Blau N., Barnes I., Dhondt J.L. International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis. 19:1996;8-14.
5. Tada K., Tateda H., Arashima S., Sakai K., Kitagawa T., Aoki K., et al. Follow-up study of a nation-wide neonatal metabolic screening program in Japan: a collaborative study group of neonatal screening for inborn errors of metabolism in Japan. Eur J Pediatr. 142:1984;204-207.
6. Tanaka Y., Matsuo N., Tsuzaki S., Araki K., Tsuchiya Y., Niederwieser A. On-off phenomenon in a child with tetrahydrobiopterin deficiency due to 6-pyruvoyl-tetrahydropterin synthase deficiency (BH4 deficiency). Eur J Pediatr. 148:1989;450-452.
7. Factor S.A., Coni R.J., Cowger M., Rosenblum E.L. Paroxysmal tremor and orofacial dyskinesia secondary to a biopterin synthesis defect. Neurology. 41:1991;930-932.
8. Hanihara T., Inoue K., Kawanishi C., Sugiyama N., Miyakawa T., Onishi H., et al. 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study. Mov Disord. 12:1997;408-411.
9. Al Aqeel A., Ozand P.T., Gascon G., Nester M., Al Nasser M., Brismar J., et al. Biopterin-dependent hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Neurology. 41:1991;730-737.
10. Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol. 11:1998;679-688.
11. Ludolph A.C., Vetter U., Ullrich K. Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability. Eur J Pediatr. 155:(Suppl):1996;S64-S68.
12. Roricht S., Meyer B.U., Irlbacher K., Ludolph A.C. Impairment of callosal and corticospinal system function in adolescents with early-treated phenylketonuria: a transcranial magnetic stimulation study. J Neurol. 246:1999;21-30.
13. Weglage J., Pietsh M., Funders B., Koch H.G., Ullrich K. Neurological findings in early treated phenylketonuria. Acta Paediatr. 84:1995;411-415.
14. Pietz J., Dunckelmann R., Rupp A., Rating D., Meinck H.M., Schmidt H., et al. Neurological outcome in adult patients with early treated phenylketonuria. Eur J Pediatr. 157:1998;824-830.
15. Van Zomeren A.H., Brouwer W.H. Clinical neurophysiology of attention. 1994;Oxford Universty Press, New York, NY.
16. Deuschl G., Eisen A. Recommendation for the practice of clinical neurophysiology: guidelines of the International Federation of Clinical Neurophysiology. 2nd ed. 1999;Elsevier, Amsterdam.
17. Lou H.C., Guttler F., Lykkelund C., Bruhn P., Niderwieser A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr. 144:1985;17-20.
18. Schmidt E., Burgard P., Rupp A. Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria. Eur J Pediatr. 155:(Suppl 1):1996;S82-S86.
19. Waisbren S.E., Brown M.J., De Sonneville L.M.J., Levy H.L. Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr. 407:(Suppl):1994;S98-S103.
20. Griffiths P., Campbell R., Robinson P. Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test. J Inherit Metab Dis. 21:1998;125-135.
21. Freeman J.S., Cody F.W., Schady W. The influence of external timing cues upon the rhythm of voluntary movements in Parkinson's disease. J Neurol Neurosurg Psychiatry. 56:1993;1078-1084.
22. Wing A.M. Voluntary timing and brain function: an information processing approach. Brain Cogn. 48:2002;7-30.
23. Shintaku H., Asada M., Sawada Y. Diagnosis and treatment of 6-pyruvoyl-tetrahydropterin synthase deficiency. Brain Dev. 22:(Suppl 1):2000;S118-S121.
24. Huijbregts S.C.J., De Sonneville L.M.J., Licht R., Van Spronsen F.J., Verkerk P.H., Sergeant J.A. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia. 40:2002;7-15.
25. Faust D., Libon D., Pueschel S. Neuropsychological functioning in treated phenylketonuria. Int J Psychiatry Med. 16:1986-87;169-177.
26. Weglage J., Schmidt E., Funders B., Pietsch M., Ullrich K. Sustained attention in untreated non-PKU-hyperphenylalaninemia. J Clin Exp Neuropsycol. 18:1996;343-348.
27. Cantello R., Gianelli M., Bettucci D., Civardi C., De Angelis M.S., Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology. 41:1991;1449-1456.
28. Ellaway P.H., Davey N.J., Maskill D.W., Dick J.P. The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjects. Electroenceph clin Neurophysiol. 97:1995;169-178.
29. McInnes R.R., Kaufman S., Warsh J.J., Van Loon G.R., Milstien S., Kapatos G., Soldin S., Walsh P., MacGregor D., Hanley W.B. Biopterin synthesis defect. J Clin Investig. 73:1984;458-469.